ASTHApollo Medical Holdings, Inc.

Nasdaq apollomed.net


$ 47.68 $ -0.22 (-0.46 %)    

Friday, 06-Sep-2024 15:59:54 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 47.64
$ 47.64 x 100
-- x --
-- - --
$ 28.87 - $ 54.27
200,144
na
1.92B
$ 1.19
$ 42.91
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-29-2020 03-31-2020 10-Q
19 03-16-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 06-29-2017 03-31-2017 10-K
31 02-14-2017 12-31-2016 10-Q
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 06-29-2016 03-31-2016 10-K
35 02-16-2016 12-31-2015 10-Q
36 11-16-2015 09-30-2015 10-Q
37 08-19-2015 06-30-2015 10-Q
38 07-14-2015 03-31-2015 10-K
39 02-23-2015 12-31-2014 10-Q
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Baird analyst Michael Ha maintains Astrana Health (NASDAQ:ASTH) with a Outperform and raises the price target from $54 to $67.

Core News & Articles

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from...

Core News & Articles

2024 Guidance:Taking all of Astrana's recent growth initiatives and capital allocation strategy into account, the Company i...

Core News & Articles

Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which missed the analyst consensus estimate of $0.4...

Core News & Articles

Stifel analyst Craig Jones maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $48 to $60.

Core News & Articles

Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 StatesExpands Payer-Agnostic Car...

Core News & Articles

Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NA...

 analyst-sees-pent-up-demand-impact-on-astrana-healths-value-based-care-model

Truist Securities upgraded Astrana Health due to its strong performance in value-based care industry.

Core News & Articles

Truist Securities analyst Jailendra Singh upgrades Astrana Health (NASDAQ:ASTH) from Hold to Buy and raises the price target...

Core News & Articles

Stifel analyst Chris O'Cull maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $48.

Core News & Articles

Baird analyst Michael Ha initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Tar...

Core News & Articles

Stifel analyst Craig Jones maintains Astrana Health (NASDAQ:ASTH) with a Buy and lowers the price target from $50 to $45.

Core News & Articles

Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.30 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION